Skip to main content
SpringerLink
Log in

Antibiotic Prescribing Patterns of French GPs for Upper Respiratory Tract Infections

Impact of Fusafungine on Rates of Prescription of Systemic Antibiotics

  • Original Research Article
  • Published:
American Journal of Respiratory Medicine

Abstract

Introduction

Despite attempts to limit their use, systemic antibiotics are extensively prescribed for respiratory infections in France. This survey analyzed data from the Thales database, which contains information from 1010 representative French general practitioners (GPs). The objective was to assess French GP prescribing patterns in upper respiratory tract infections (URTIs) including the rate of prescription of systemic antibiotics and anti-inflammatory drugs in the presence or absence of prescribing fusafungine (Locabiotal®), an antibiotic with anti-inflammatory activity indicated for local use in URTIs. Drug costs to the French National Sickness Fund were also assessed.

Methods

This was a retrospective, longitudinal, case-control analysis. Prescribing patterns and costs were compared between patients who did and patients who did not receive fusafungine for a URTI (rhinopharyngitis, tonsillitis, or an influenza-like condition). The fusafungine group consisted of all patients in the database who were prescribed fusafungine at least once between 1 December 1999 and 30 November 2000. The control group was made up of randomly selected patients, matched for age and sex with the study group, who received at least one drug prescription (but not fusafungine) for a URTI during the same period. Patients were selected at the time of their first prescription, and their records for 1 year were analyzed.

Results

Each group contained 22 164 patients. For URTIs overall, systemic antibiotics were widely prescribed (at a rate of 54.6% and 67.8% in the fusafungine and control groups, respectively; p < 0.01). The rate of prescription of systemic antibiotics, NSAIDs and corticosteroids per prescription and per episode was significantly lower in the fusafungine group than in the control group.

The mean cost per prescription for the French National Sickness Fund was significantly lower for the three URTIs overall when fusafungine was prescribed (9.21 euros [€] vs €9.67; p < 0.01). The mean cost to the National Sickness Fund per prescription of systemic antibiotics, NSAIDs, and corticosteroids was also significantly lower in the fusafungine group compared with the control group. The cost of nasal preparations was higher in the fusafungine group because Locabiotal® is classified as a nasal preparation.

The cost per prescription to the National Sickness Fund was increased by the presence of systemic antibiotics, NSAIDs, or corticosteroids among the prescribed drugs and decreased with the prescription of fusafungine.

Conclusion

When fusafungine was prescribed for URTIs, fewer systemic antibiotics were prescribed, an important result in the current context of concern about emerging antibiotic resistance. The use of fusafungine was associated with a lower mean cost per prescription to the French National Sickness Fund.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Table IV
Table V

Similar content being viewed by others

Notes

  1. 1The use of tradenames is for product identification purposes only and does not imply endorsement.

References

  1. Gonzales R, Malone DC, Maselli JH, et al. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001; 15: 757–62

    Article  Google Scholar 

  2. Witte W. Antibiotic resistance in Gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother 1999; 44: 1–9

    Article  PubMed  CAS  Google Scholar 

  3. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851–3

    Article  PubMed  CAS  Google Scholar 

  4. Guillemot D. Les antibiotiques sont-ils surconsommés? Rev Prat 1998; 48: 585–6

    PubMed  CAS  Google Scholar 

  5. Centre de Coordination de la Lutte contre les Infections Nosocomiales de l’ Interrégion Paris-Nord (CCLIN Paris-Nord). Surveillance des bactéries multirésistantes à partir du laboratoire dans les hôpitaux de l’ interrégion Paris- Nord (hors assistance Publique-Hôpitaux de Paris): rapport des résultats 2001. Paris: CCLIN Paris-Nord, 2002

    Google Scholar 

  6. Klugman KP, Goldstein F, Kohno S, et al. The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci. Clin Microbiol Infect 1997; 3Suppl. 1: S48–60

    Article  Google Scholar 

  7. Laurans G, Murbach V, Cattier B, et al. Observatoires régionaux du pneumocoque: surveillance de la sensibilité aux antibiotiques des pneumocoques isolés en situation pathogène en France en 1999 [online]. B.E.H. 2001 no. 33. Available from URL: http://www.invs.sante.fr/beh/2001/33/index.htm [Accessed 2003 Oct 13]

  8. Chaix C, Durand-Zaleski I, Alberti C, et al. Control of endemic methicillinresistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999; 282: 1745–51

    Article  PubMed  CAS  Google Scholar 

  9. Ball P, Baquero F, Cars O, et al. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. The Consensus Group on Resistance and Prescribing In Respiratory Tract Infection. J Antimicrob Chemother 2002; 49: 31–40

    Article  PubMed  CAS  Google Scholar 

  10. Agence du Médicament. Antibiothérapie par voie générale en pratique courante: infections ORL et respiratoires basses. Presse Med 1999; 28: 406–14

    Google Scholar 

  11. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001; 134: 479–86

    PubMed  CAS  Google Scholar 

  12. Agence Francaise de Sécurité Sanitaire des Produits de Santé (AFSSaPS). Antibiothérapie par voie generale en pratique courante: infections ORL et respiratoires basses. Ann Otolaryngol Chir Cervicofac 1999; 116: 302–14

    Google Scholar 

  13. Bradley CP. Decision making and prescribing patterns: a literature review. Fam Pract 1991; 8: 276–87

    Article  PubMed  CAS  Google Scholar 

  14. Greenhalgh T, Gill P. Pressure to prescribe. BMJ 1997; 315: 1482–3

    Article  PubMed  CAS  Google Scholar 

  15. Cockburn J, Pit S. Prescribing behaviour in clinical practice: patients’ expectations and doctors’ perceptions of patients’ expectations: a questionnaire study. BMJ 1997; 315: 520–3

    Article  PubMed  CAS  Google Scholar 

  16. Portier H. Résultat de l’évaluation du test de diagnostic rapide dans les angines. Abstract ORL-Pneumo-Allergo 2002; 2: 4–5

    Google Scholar 

  17. Guéniot C. Actualités des angines. Panorama Médecin 2001; 4824: 20

    Google Scholar 

  18. Caisse nationale d’assurance maladie. Mieux utiliser les antibiotiques, c’est préserver leur efficacité. Concours Med 2002; 124–23: 1614

    Google Scholar 

  19. Agence du Médicament. Prescription et consommation des antibiotiques en ambulatoire. Presse Med 1999; 28: 343–50

    Google Scholar 

  20. German-Fattal M. Fusafungine: an antimicrobial agent for the local treatment of respiratory tract infections. Clin Drug Invest 1996; 12: 308–17

    Article  CAS  Google Scholar 

  21. German-Fattal M. Fusafungine, an antimicrobial with anti-inflammatory properties in respiratory tract infections. Clin Drug Invest 2001; 21: 653–70

    Article  CAS  Google Scholar 

  22. Cuénant G. Value of Locabiotal® aerosol in rhinosinusitis. Rhinology Suppl 1988; 5: 69–74

    Google Scholar 

  23. Reinert P. Intérêt des test rapides pour la detection des infections streptococciques: illustration par une étude sur Locabiotal Pressuriseé dans les amygdalites. Maladies Médicaments 1989; 5: 113–23

    Google Scholar 

  24. Samolinski B, Zawisza E, Arcimowicz M, et al. Influence of fusafungine upon viral and bacterial infections. Med Sci Monit 1997; 3: 736–43

    Google Scholar 

  25. Bisno AL, Gerber MA, Gwaltney Jr JM, et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002; 35: 113–25

    Article  PubMed  Google Scholar 

  26. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med 2001; 134: 490–4

    PubMed  CAS  Google Scholar 

  27. Hickner JM, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001; 34: 498–505

    Google Scholar 

  28. Cooper RJ, Hoffmann JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001; 134: 509–17

    PubMed  CAS  Google Scholar 

  29. Guillemot D, Carbon C, Vauzelle-Kervroedan F, et al. Inappropriateness and variability of antibiotic prescription among French office-based physicians. J Clin Epidemiol 1998; 51: 61–8

    Article  PubMed  CAS  Google Scholar 

  30. Guillemot D, Maison P, Carbon C, et al. Trends in antimicrobial drug use in the community: France, 1981–1992. J Infect Dis 1998; 177: 492–7

    Article  PubMed  CAS  Google Scholar 

  31. Bouvenot G. French National Institute for prescriptions and consumption of medicines: prescriptions and consumption of antibiotics for respiratory infections. Bull Acad Natl Med 1999; 183: 601–13

    PubMed  CAS  Google Scholar 

  32. Gerber MA, Randolph MF, Chanatry J, et al. Antigen detection test for streptococcal pharyngitis: evaluation of sensitivity with respect to true infections. J Pediatr 1986; 108: 654–8

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The analysis of the data and preparation of this paper were supported by Les Laboratoires Servier, Neuilly-sur-Seine, France.

Author information

Authors and Affiliations

  1. CEMKA-EVAL, 43, Bd du Maréchal Joffre, 92340, Bourg-la-Reine, France

    Francis Fagnani

  2. Centre d’Etudes Pharmaceutiques, Université de Paris XI, Châtenay-Malabry, France

    Michèle German-Fattal

Authors
  1. Francis Fagnani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michèle German-Fattal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francis Fagnani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fagnani, F., German-Fattal, M. Antibiotic Prescribing Patterns of French GPs for Upper Respiratory Tract Infections. Treat Respir Med 2, 491–498 (2003). https://doi.org/10.1007/BF03256676

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03256676

Keywords

Search

Navigation